Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking

The American Journal of Clinical Nutrition
1997.0

Abstract

Using a reliable, newly developed assay for ascorbic acid (reduced form) and dehydroascorbic acid (DHAA; the oxidized form) in plasma, we studied the influence of age, sex, and smoking on 219 healthy, age-stratified, and randomly selected subjects representing the Danish population. The mean (+/-SD) plasma total ascorbic acid (ascorbic acid + DHAA) concentration was lower in smokers (62.8 +/- 24.9 mumol/L) than in nonsmokers (74.9 +/- 23.6 mumol/L) (P < 0.001) and the DHAA content was 1.8 +/- 4.0% of the total ascorbic acid in smokers compared with 0.1 +/- 3.1% in nonsmokers (P < 0.001). A significant inverse correlation between the DHAA fraction and the total ascorbic acid concentration was found in smokers (P < 0.002) but not in smokers; the slopes of the linear regressions were significantly different in the two groups (P < 0.005). The mean plasma concentration of total ascorbic acid was higher in females than in males (P < 0.005); this difference persisted in multivariate analysis when smoking was adjusted for. No age dependence could be identified. The data show that smoking results in severe oxidative stress, depletion of the ascorbic acid pool, and insufficient reduction capacity to maintain ascorbic acid in the reduced form in plasma. We suggest that the additional analysis of DHAA allows further differentiation in the assessment of oxidative stress and may provide an objective way of determining vitamin C requirements in smokers. Preliminary findings suggest that a vitamin C dose that results in a plasma concentration of approximately 70 mumol/L or higher is required in smokers.

Knowledge Graph

Similar Paper

Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking
The American Journal of Clinical Nutrition 1997.0
Almond Consumption Reduces Oxidative DNA Damage and Lipid Peroxidation in Male Smokers ,
The Journal of Nutrition 2007.0
High-Performance Liquid Chromatography-Electrochemical Determination of Salicylate Hydroxylation Products as an in Vivo Marker of Oxidative Stress
Analytical Biochemistry 1995.0
Measurement of oxysterols and α-tocopherol in plasma and tissue samples as indices of oxidant stress status
Analytical Biochemistry 2003.0
Antioxidant capacity of human blood plasma and human urine: Simultaneous evaluation of the ORAC index and ascorbic acid concentration employing pyrogallol red as probe
Bioorganic &amp; Medicinal Chemistry 2008.0
Determination of nicotine and four metabolites in the serum of smokers by high-performance liquid chromatography with ultraviolet detection
Journal of Chromatography B: Biomedical Sciences and Applications 1993.0
Understanding the human salivary metabolome
NMR in Biomedicine 2009.0
Effects of smoking on trace metal levels in saliva
Oral Diseases 2010.0
Quantification of urinary o,o′-dityrosine, a biomarker for oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometryA comparison with ion-trap tandem mass spectrometry
Journal of Chromatography B 2005.0
Antioxidant capacity of BO-653, 2,3-dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran, and uric acid as evaluated by ORAC method and inhibition of lipid peroxidation
Bioorganic &amp; Medicinal Chemistry Letters 2008.0